Back to CVE records
Critical 9.3Published May 27, 2026

CVE-2026-35087Slican telephone exchanges allow administrative protocol authentication bypass.

Updated under an hour ago ()

Does this affect you?

It lists no affected products yet. Add what you run and Signals checks it as products are added.

No exploitation reported and no EPSS estimate yet.

Slican telephone exchanges allow administrative protocol authentication bypass. An attacker can bypass the need to enter login credentials by executing the appropriate command. This issue was fixed in versions below: - NCP: version 1.24.0250 - IPx series: version 6.61.0040 - CCT-1668: version 6.56.0430 - MAC-6400: version 6.56.0430 - CXS-0424: version 6.30.0510 The issue STILL EXISTS in End-Of-Life telephone exchanges in versions 4.xx and below: - CCT-1668 (CCT1CPU) - MAC-6400 - CXS-0424 These products were discontinued in 2011 and 2012 and and will not receive updates. These products require a hardware update in order to receive a software update. The vendor recommends that users of these devices contact the their service department directly to determine the options for upgrading.

CVSS
9.3 CRITICAL (v4.0, NVD)CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Weakness (CWE)
CWE-288
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Deferred
Record last updated
Jun 17, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

No affected products are listed yet.

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.